drugset / Trial / NCT04831541

68Ga-PSMA-11 PET/CT in Patients With Various Types of Cancer

NCT04831541

NaSingle-groupOpen-labelDiagnostic

Summary

To evaluate the potential usefulness of 68Ga-PSMA-11 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions, efficacy assessment and recurrence monitoring in various types of cancer.

Timeline

Start
2020-10-10
Primary completion
2024-12-30
Completion
2024-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject 68Ga-PSMA-11 Diagnostic / imaging agent Intravenous

Indications